SN
Sanofi
SNYNF · OTC
$82.82 -2.97% (-$2.53)
1M -10.50%
Market Cap 89.4B €
P/E Ratio 13.22x
Div. Yield 5.67%
ROE 9.43%
Bulios Fair Price
$60.43
27.0% downside
Current Price
$82.82
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SNYNF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
96 /100
Cheap P/E 13.22x
P/FCF 5.43x
EV/EBITDA 7.73x
Growth
28 /100
Declining EPS growth 1.32%
Book val. growth 1.56%
Rev. growth 2.66%
Profitability
94 /100
Strong Gross margin 72.32%
FCF margin 27.25%
Net margin 11.18%
Quality
52 /100
Average ROIC 11.77%
Asset turnover 0.47x
ROE 9.43%
Debt
78 /100
Low Debt/Equity 0.34x
Net debt/EBITDA 1.25x
Current ratio 0.99x
Stability
66 /100
Moderate Beta 0.30x
Profitable years 6
Rev. volatility 4.00%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SNYNF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Belén Garijo López
Employees
76,493
Headquarters
Paris
Upcoming events
30 OCT
Earnings
Upcoming earnings report